Author, country, and study year | Disease type and age | Setting | Neonatal Isolation rate and aetiology* | |
---|---|---|---|---|
Sub-Saharan Africa | Â | Â | Â | Â |
Blomberg et al. [10] | Bacteremia | urban, hospital recruitment | 54 early onset (EOS) isolates †: 31 late onset (LOS) isolates: | |
Tanzania 2001-2002 | <7Â yrs | Â | Klebsiella spp. | EOS 14 (26%), LOS 7 (23%) |
 |  |  | S. aureus | EOS 6 (11%), LOS 5 (16%) |
 |  |  | E. coli | EOS 6 (11%), LOS 3 (10%) |
 |  |  | Group B Streptococcus | EOS 2 (4%), LOS 1 (3%) |
Sigaúque et al. [21] | Bacteremia | rural, hospital recruitment | 154 isolates: 16% blood cultures positive | |
Mozambique 2001-2006 | <15Â yrs | Â | S. aureus | 60 (39%) |
 |  |  | Group B Streptococcus | 31 (20%) |
 |  |  | E. coli | 9 (6%) |
 |  |  | S. pneumoniae | 7 (5%) |
Nielsen et al. [17] | Bacteremia | rural, hospital recruitment | 23 isolates: | Â |
Ghana 2007-2009 | <5Â yrs | Â | S. aureus | 6 (26%) |
 |  |  | Klebsiella spp. | 6 (26%) |
 |  |  | Streptococcus spp. | 3 (13%) |
 |  |  | E. coli | 3 (13%) |
 |  |  | Non-tyhoid Salmonella | 2 (9%) |
Gray et al. [29] | Group B streptococcus | urban, hospital recruitment | 290 isolates: 12% blood cultures positive | |
Malawi 2004-2005 | <90Â days | Â | Group B Streptococcus | 48 (17%) |
Talbert et al. [24] | Neonatal sepsis | rural, hospital recruitment | 474 isolates: 9% blood cultures positive (25 infants had 2 bacterial species isolated) | |
Kenya 2001-2009 | <60Â days | Â | Klebsiella spp. | 57 (13%) |
 |  |  | S. aureus | 55 (12%) |
 |  |  | Acinetobacter spp. | 48 (11%) |
 |  |  | E. coli | 41 (9%) |
 |  |  | Group B Streptococcus | 32 (7%) |
 |  |  | 86 isolates from CSF samples : 4% CSF cultures positive | |
 |  |  | S. pneumoniae | 17 (20%) |
 |  |  | Group B Streptococcus | 16 (19%) |
 |  |  | Salmonella spp. | 10 (12%) |
Ojukwu et al. [18] | Neonatal sepsis | urban, hospital recruitment | 33 isolates: 24% blood cultures positive | |
Nigeria 2002-2003 | 0-28 days | Â | S. aureus | 15 (45%) |
 |  |  | E. coli | 6 (18%) |
 |  |  | Klebsiella spp. | 3 (9%) |
 |  |  | Group B Streptococcus | 1 (3%) |
Mugalu et al. [15] | Neonatal sepsis | urban, hospital recruitment | 110 isolates: 37% blood or CSF cultures positive | |
Uganda 2002 | used WHO guidelines | Â | S. aureus | 69 (63%) |
 |  |  | E. coli | 17 (15%) |
 |  |  | Group B Streptococcus | 7 (6%) |
Shitaye et al. [19] | Neonatal sepsis | urban, hospital recruitment | 135 isolates: 45% blood cultures positive | |
Ethiopia 2006-2007 | 0-28 days | Â | Klebsiella spp. | 53 (39%) |
 |  |  | S. aureus | 30 (22%) |
 |  |  | Coagulase-negative Staphylococcus | 10 (7%) |
Mhada et al. | Neonatal sepsis | urban, hospital recruitment | 52 early onset (EOS) isolates †: 22 late onset (LOS) isolates: 22.4% blood cultures positive | |
Tanzania 2009-2010 | 0-28 days | Â | S. aureus | EOS 15 (29%), LOS 12 (55%) |
 |  |  | Klebsiella spp. | EOS 17 (33%), LOS 5 (23%) |
 |  |  | E. coli | EOS 10 (19%), LOS 4 (18%) |
 |  |  | Staphylococcus epidermidis | EOS 6 (12%), LOS 0 (0%) |
 |  |  | Group B Streptococcus | EOS 1 (2%), LOS 0 (0%) |
Kiwanuka et al. [13] | Neonatal sepsis | urban, hospital recruitment | 19 early onset (EOS) isolates †: 7 late onset (LOS) isolates: 33% blood cultures | |
Uganda 2010 | <1Â month | Â | S. aureus | EOS 13 (68%), LOS 3 (43%) |
 |  |  | E. coli | EOS 3 (16%), LOS 1 (14%) |
 |  |  | Klebsiella spp. | EOS 1 (5%), LOS 1 (14%) |
 |  |  | Group B Streptococcus | EOS 1 (5%), LOS 0 (0%) |
SE Asia | Â | Â | Â | Â |
Stoesser et al. [22] | Bacteremia | urban, hospital recruitment | 65 isolates: | |
Cambodia 2007-2011 | <16Â yrs | Â | Klebsiella spp. | 14 (22%) |
 |  |  | S. aureus | 9 (14%) |
 |  |  | Enterobacter spp. | 4 (6%) |
 |  |  | E. coli | 3 (5%) |
 |  |  | Streptococcus pyogenes | 3 (5%) |
Kruse et al. [30] | Neonatal sepsis | urban, hospital recruitment | 399 isolates: 17% blood cultures positive | |
Vietnam 2009-2010 | <28Â days | Â | Klebsiella spp. | 78 (20%) |
 |  |  | Acinetobacter spp. | 58 (15%) |
 |  |  | E. coli | 21 (5%) |
 |  |  | Enterobacter spp. | 16 (4%) |
 |  |  | S. aureus | 11 (3%) |
 |  |  | Morganella spp. | 8 (2%) |
 |  |  | Pseudomonas spp. | 6 (2%) |
 |  |  | Coagulase-negative Staphylococcus | 175 (44%) |
India subcontinent | Â | Â | Â | Â |
Mir et al. [28] | Omphalitis with sepsis | urban, community recruitment | 432 isolates: 64% umbilical cord cultures positive | |
Pakistan 2004-2007 | neonates (<1 month) |  | S. aureus | 225 (52%)‡ |
 |  |  | Streptococcus pyogenes | 78 (18%)‡ |
 |  |  | Group B Streptococcus | 43 (10%)‡ |
Jain et al. [26] | Neonatal sepsis | urban, hospital recruitment | 350 isolates: 48% blood cultures positive for bacteria | |
India 2001-2002 | Not defined |  | Klebsiella spp. | 86 (25%)‡ |
 |  |  | Enterobacter spp. | 80 (23%)‡ |
 |  |  | E. coli | 49 (14%)‡ |
Sundaram et al. [23] | Neonatal sepsis | urban, hospital recruitment | 527 early onset (EOS) isolates § : 364 late onset (LOS) isolates: | |
India 1995–1998, 2001-2006 | Not defined |  | S. aureus | EOS 108 (20%), LOS 112 (31%) |
 |  |  | K. pneumoniae | EOS 62 (12%), LOS 49 (14%) |
 |  |  | Non-fermenting gram negative bacilli | EOS 161 (30%), LOS 60 (17%) |
 |  |  | E. coli | EOS 48 (9%), LOS 40 (11%) |
Zakariya et al. [25] | Neonatal sepsis | urban, hospital recruitment | 50 isolates: 42% blood cultures positive | |
India 2004-2006 | <= 30Â days | Â | K. pneumoniae | 33 (66%) |
 |  |  | Coagulase-negative Staphylococcus | 6 (12%) |
 |  |  | Group B Streptococcus | 1 (2%) |
Muhammad et al. [16] | Neonatal sepsis | urban, hospital recruitment | 130 isolates: | Â |
Pakistan 2009-2010 | <28Â days | Â | S. aureus | 35 (27%) |
 |  |  | E. coli | 30 (23%) |
 |  |  | Staphylococcus epidermidis | 17 (13%) |
 |  |  | Acinetobacter spp. | 17 (13%) |
 |  |  | Klebsiella spp. | 13 (10%) |
 |  |  | Streptococcus species only found in early onset sepsis (first week) | |
 |  |  | Klebseilla species only found in late onset sepsis (after first week to 28 days) | |
Darmstadt et al. [27] | Neonatal sepsis | rural, community recruitment | 29 isolates: 6% blood cultures positive | |
Bangladesh 2004-2006 | <28Â days | Â | S. aureus | 10 (34%) |
 |  |  | S. pneumoniae | 3 (10%) |
 |  |  | Group B Streptococcus | 1 (3%) |
Gyawali et al. [12] | Neonatal sepsis | urban, hospital recruitment | 238 isolates: 15% blood cultures positive | |
Nepal 2009-2010 | first 4Â weeks of life | Â | S. aureus | 94 (40%) |
 |  |  | Klebsiella spp. | 32 (14%) |
 |  |  | Acinetobacter spp. | 30 (13%) |
 |  |  | Enterobacter spp. | 27 (11%) |
 |  |  | Pseudomonas spp. | 21 (9%) |
 |  |  | E. coli | 16 (7%) |
Shresta et al. [20] | Neonatal sepsis | urban, hospital recruitment | 37 isolates: 32% blood cultures positive | |
Nepal, 2011-2012 | not defined | Â | S. aureus | 21 (57%) |
 |  |  | K. pneumoniae | 8 (22%) |
 |  |  | P. aeruginosa | 5 (13%) |
Europe | Â | Â | Â | Â |
Macharashvili et al. [14] | Neonatal sepsis | urban, hospital recruitment | 126 isolates: 67% blood cultures positive | |
Georgia 2003-2004 | 8Â weeks or younger | Â | K. pneumoniae | 36 (29%) |
 |  |  | Enterobacter cloacae | 19 (15%) |
 |  |  | S. aureus | 15 (12%) |
 |  |  | Group B Streptococcus | 6 (5%) |